Last reviewed · How we verify
PROBAMPACIN (AMPICILLIN/AMPICILLIN TRIHYDRATE)
PROBAMPACIN (generic name: AMPICILLIN/AMPICILLIN TRIHYDRATE) is a drug developed by COSETTE. It is currently FDA-approved.
PROBAMPACIN is a small molecule with the same chemical structure as ampicillin/ampicillin monohydrate.
At a glance
| Generic name | AMPICILLIN/AMPICILLIN TRIHYDRATE |
|---|---|
| Sponsor | COSETTE |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Acupuncture and Herbal Treatment of Chronic HIV Sinusitis (NA)
- Bacteriological Study of Acute Follicular Tonsillitis in Patients Attending the ENT Outpatient Clinic of Assiut University Hospital (N/A)
- Safety, Validity and Efficiency of a Direct Graded Oral Challenge With Amoxicillin for the Evaluation of Penicillin Allergy in Adults (NA)
- Pharmacokinetics and Pharmacodynamic (PK/PD) of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock (Phase 3)
- Ampicillin-sulbactam Resistant E.Coli at UPMC (N/A)
- A Phase 3, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Cefepime-AAI101 Compared to Piperacillin/Tazobactam in the Treatment of Complicated Urinary Tract Infections, Includin (Phase 3)
- 14-day Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in the Treatment of Helicobacter Pylori Infection Complicated With Functional Dyspepsia:A Single-Center,Randomized Contr (Phase 3)
- Prophylactic Antibiotics After Functional Endoscopic Sinus Surgery: a Randomized, Double-blind Placebo Controlled Trial (Phase 4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PROBAMPACIN CI brief — competitive landscape report
- PROBAMPACIN updates RSS · CI watch RSS
- COSETTE portfolio CI
Frequently asked questions about PROBAMPACIN
What is PROBAMPACIN?
PROBAMPACIN (AMPICILLIN/AMPICILLIN TRIHYDRATE) is a pharmaceutical drug developed by COSETTE.
Who makes PROBAMPACIN?
PROBAMPACIN is developed and marketed by COSETTE (see full COSETTE pipeline at /company/cosette).
What is the generic name of PROBAMPACIN?
AMPICILLIN/AMPICILLIN TRIHYDRATE is the generic (nonproprietary) name of PROBAMPACIN.
What development phase is PROBAMPACIN in?
PROBAMPACIN is FDA-approved (marketed).
Related
- Manufacturer: COSETTE — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing